Prolonged dual antiplatelet therapy for Chinese ACS patients undergoing emergency PCI with drug-eluting stents: Benefits and risks

Prolonged dual antiplatelet therapy for Chinese ACS patients undergoing emergency PCI with drug-eluting stents: Benefits and risks

BackgroundIn patients with acute coronary syndrome (ACS), prolonged dual antiplatelet therapy (DAPT) may reduce ischemic events and increase the risks of bleeding events differently in different ethnic groups. However, whether prolonged DAPT in Chinese patients with ACS following emergency percutane...

Full description

Bibliographic Details
Main Authors:	Yong Zhang, Chao Chu, Zhong Zhong, Yong-bai Luo, Fei-Fei Ning, Ning Guo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	dual antiplatelet therapy (DAPT) acute coronary syndrome (ACS) major adverse cardiovascular and cerebrovascular event (MACCE) composite bleeding event emergency percutaneous coronary intervention (PCI)
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1080673/full

Similar Items

Thirty-Days versus Longer Duration of Dual Antiplatelet Treatment after Percutaneous Coronary Interventions with Newer Drug-Eluting Stents: A Systematic Review and Meta-Analysis
by: Grigorios Tsigkas, et al.
Published: (2023-02-01)

Risk prediction of bleeding and MACCE by PRECISE-DAPT score post-PCI
by: Lisa Dannenberg, et al.
Published: (2021-04-01)

Bleeding Severity in Percutaneous Coronary Intervention (PCI) and Its Impact on Short-Term Clinical Outcomes
by: Shashank Murali, et al.
Published: (2020-05-01)

Antiplatelet Therapy in High-Bleeding Risk Patients Undergoing PCI: Walking a Tightrope
by: Davis Jones, et al.
Published: (2022-06-01)

Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) Concentrations
by: Kongyong Cui, et al.
Published: (2021-12-01)

The effects of dual antiplatelet therapy (DAPT) adherence on survival in patients undergoing revascularization and the determinants of DAPT adherence
by: Shuqi Zhang, et al.
Published: (2022-05-01)

Predictors and Management of Antiplatelet-Related Bleeding Complications for Acute Coronary Syndrome in Chinese Elderly Patients
by: Jindong Wan, et al.
Published: (2018-10-01)

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
by: Marie Muthspiel, et al.
Published: (2022-11-01)

Antiplatelet Therapy in Acute Coronary Syndrome
by: I. M. Kuzmina, et al.
Published: (2022-01-01)

Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review
by: Grigorios Tsigkas, et al.
Published: (2023-03-01)

Novel antiplatelet targets in the treatment of acute coronary syndromes
by: Fawaz O. Alenazy, et al.
Published: (2021-01-01)

Age and outcomes following personalized antiplatelet therapy in chronic coronary syndrome patients: a post hoc analysis of the randomized PATH-PCI trial
by: Ying Pan, et al.
Published: (2023-12-01)

One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients
by: Carlo A. Pivato, et al.
Published: (2022-03-01)

Dual Antiplatelet Therapy: A Concise Review for Clinicians
by: Hafeez Ul Hassan Virk, et al.
Published: (2023-07-01)

Performance of PRECISE-DAPT and Age–Bleeding–Organ Dysfunction Score for Predicting Bleeding Complication During Dual Antiplatelet Therapy in Chinese Elderly Patients
by: Liang Dong, et al.
Published: (2022-07-01)

High triglyceride–glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents
by: Yong Zhang, et al.
Published: (2023-02-01)

Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention
by: Pham PT
Published: (2011-08-01)

Clinical benefit of long-term use of dual antiplatelet therapy for acute myocardial infarction patients with the PEGASUS-TIMI 54 criteria
by: Kwan Yong Lee, et al.
Published: (2022-11-01)

Long-term dual antiplatelet treatment and bleeding complications in diabetic patients treated with drug eluting stent implantation
by: Vassilis Voudris, et al.
Published: (2014-12-01)

Can antiplatelet therapy after drug eluting stent become a problem?
by: Michele Romano
Published: (2009-03-01)

Association between Contrast Media Volume and 1-Year Clinical Outcomes in Patients Undergoing Coronary Angiography
by: Ying-Qing Feng, et al.
Published: (2018-01-01)

Is the duration of dual antiplatelet therapy (DAPT) excessive in post-angioplasty in chronic coronary syndrome? Data from the France-PCI registry (2014–2019)
by: A. Mezier, et al.
Published: (2023-03-01)

Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice
by: Liam Mullen, et al.
Published: (2021-04-01)

Safety of 3‐Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus‐Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART‐CHOICE Trial
by: Kyeong Ho Yun, et al.
Published: (2021-01-01)

One-Stop Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Grafting in Patients With Multivessel Coronary Artery Disease
by: Dongjie Li, et al.
Published: (2021-12-01)

Prasugrel Inappropriate Use in Patients Post-percutaneous coronary intervention (PCI). A Single Center Study
by: Ahmed Amro, et al.
Published: (2019-07-01)

The Pharmacological Approach to Oncologic Patients with Acute Coronary Syndrome
by: Juri Radmilovic, et al.
Published: (2020-12-01)

Clinical Impact of Dual Antiplatelet Therapy Use in Patients Following Everolimus-eluting Stent Implantation: Insights from the SEEDS Study
by: Yao-Jun Zhang, et al.
Published: (2015-01-01)

Short Versus Long-Term Dual Antiplatelet Therapy in Patients at High Bleeding Risk Undergoing PCI in Contemporary Practice: A Systemic Review and Meta-analysis
by: Nader Mankerious, et al.
Published: (2023-06-01)

Ticagrelor monotherapy after a short course of dual antiplatelet therapy with ticagrelor plus aspirin following percutaneous coronary intervention in patients with versus without diabetes mellitus: a meta-analysis of randomized trials
by: Chen Ning, et al.
Published: (2024-03-01)

Validation of the DAPT score in large-scale consecutive and contemporary patients population in the real world
by: Guofeng Gao, et al.
Published: (2021-11-01)

Performance of the REACH, PARIS, BleeMACS, and PRECISE-DAPT scores for predicting 1-year bleeding events in patients undergoing coronary drug-eluting stent implantation
by: Si-Qi Lyu, et al.
Published: (2022-07-01)

Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review
by: Gabriele Carciotto, et al.
Published: (2023-11-01)

Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention
by: Zhigang Zhao, et al.
Published: (2023-03-01)

Prognostic value of the PDW/HDL-C ratio in patients with chest pain symptoms and coronary artery calcification
by: Ya-Jing Qiu, et al.
Published: (2022-07-01)

Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
by: Gwang-Seok Yoon, et al.
Published: (2021-07-01)

Efficacy and safety of ticagrelor versus clopidogrel with different dosages in acute coronary syndrome patients with high GRACE and CRUSADE scores
by: Peng Xiao, et al.
Published: (2021-05-01)

Sex-related differences in clinical outcomes and predictive factors in the very elderly patients with ACS undergoing PCI
by: Jia-li Wang, et al.
Published: (2022-09-01)

Long-term outcomes of extending dual antiplatelet therapy after drug-eluting stent implantation for acute coronary syndrome: a large single-center study
by: Jingjing Xu, et al.
Published: (2020-10-01)

Deceleration Capacity Improves Prognostic Accuracy of Relative Increase and Final Coronary Physiology in Patients With Non-ST-Elevation Acute Coronary Syndrome
by: Jun Wang, et al.
Published: (2022-03-01)